 
--S.845--
S.845
One Hundred First Congress of the United States of America
AT THE SECOND SESSION
Begun and held at the City of Washington on Tuesday, the twenty-third day
of January,
one thousand nine hundred and ninety
An Act
To amend the Federal Food, Drug, and Cosmetic Act to revitalize the Food
and Drug
Administration, and for other purposes.
 Be it enacted by the Senate and House of Representatives of the United
 States of America in Congress assembled,
SECTION 1. SHORT TITLE; TABLE OF CONTENTS.
 (a) SHORT TITLE- This Act may be cited as the `Food and Drug Administration
 Revitalization Act'.
 (b) TABLE OF CONTENTS- The table of contents is as follows:
Sec. 1. Short title; table of contents.
Sec. 2. References to the Federal Food, Drug, and Cosmetic Act.
TITLE I--CONSOLIDATED ADMINISTRATIVE AND LABORATORY FACILITY
Sec. 101. Consolidated administrative and laboratory facility.
TITLE II--RECOVERY AND RETENTION OF FEES FOR FOIA REQUESTS
Sec. 201. Recovery and retention of fees for FOIA requests.
TITLE III--SCIENTIFIC REVIEW GROUPS
Sec. 301. Scientific review groups.
TITLE IV--AUTOMATION OF FDA
Sec. 401. Automation of FDA.
SEC. 2. REFERENCES TO THE FEDERAL FOOD, DRUG, AND COSMETIC ACT.
 Except as otherwise specifically provided, whenever in this Act an amendment
 or repeal is expressed in terms of an amendment to, or repeal of, a section
 or other provision, the reference shall be considered to be made to a
 section or other provision of the Federal Food, Drug, and Cosmetic Act
 (21 U.S.C. 301 et seq.).
TITLE I--CONSOLIDATED ADMINISTRATIVE AND LABORATORY FACILITY
SEC. 101. CONSOLIDATED ADMINISTRATIVE AND LABORATORY FACILITY.
 Chapter VII (21 U.S.C. 371 et seq.) is amended by adding at the end thereof
 the following new section:
`SEC. 710. CONSOLIDATED ADMINISTRATIVE AND LABORATORY FACILITY.
 `(a) AUTHORITY- The Secretary, in consultation with the Administrator of the
 General Services Administration, shall enter into contracts for the design,
 construction, and operation of a consolidated Food and Drug Administration
 administrative and laboratory facility.
 `(b) AWARDING OF CONTRACT- The Secretary shall solicit contract proposals
 under subsection (a) from interested parties. In awarding contracts under such
 subsection, the Secretary shall review such proposals and give priority to
 those alternatives that are the most cost effective for the Federal Government
 and that allow for the use of donated land, federally owned property, or
 lease-purchase arrangements. A contract under this subsection shall not be
 entered into unless such contract results in a net cost savings to the Federal
 Government over the duration of the contract, as compared to the Government
 purchase price including borrowing by the Secretary of the Treasury.
 `(c) DONATIONS- In carrying out this section, the Secretary shall have the
 power, in connection with real property, buildings, and facilities, to accept
 on behalf of the Food and Drug Administration gifts or donations of services
 or property, real or personal, as the Secretary determines to be necessary.
 `(d) AUTHORIZATION OF APPROPRIATIONS- There are authorized to be appropriated
 to carry out this section $100,000,000 for fiscal year 1991, and such sums
 as may be necessary for each of the subsequent fiscal years, to remain
 available until expended.'.
TITLE II--RECOVERY AND RETENTION OF FEES FOR FOIA REQUESTS
SEC. 201. RECOVERY AND RETENTION OF FEES FOR FOIA REQUESTS.
 Chapter VII (21 U.S.C. 371 et seq.) (as amended by section 101 of this Act)
 is further amended by adding at the end thereof the following new section:
`SEC. 711. RECOVERY AND RETENTION OF FEES FOR FREEDOM OF INFORMATION REQUESTS.
 `(a) IN GENERAL- The Secretary, acting through the Commissioner of Food
 and Drugs, may--
 `(1) set and charge fees, in accordance with section 552(a)(4)(A) of
 title 5, United States Code, to recover all reasonable costs incurred in
 processing requests made under section 552 of title 5, United States Code,
 for records obtained or created under this Act or any other Federal law
 for which responsibility for administration has been delegated to the
 Commissioner by the Secretary;
 `(2) retain all fees charged for such requests; and
 `(3) establish an accounting system and procedures to control receipts and
 expenditures of fees received under this section.
 `(b) USE OF FEES- The Secretary and the Commissioner of Food and Drugs shall
 not use fees received under this section for any purpose other than funding
 the processing of requests described in subsection (a)(1). Such fees shall
 not be used to reduce the amount of funds made to carry out other provisions
 of this Act.
 `(c) WAIVER OF FEES- Nothing in this section shall supersede the right of
 a requester to obtain a waiver of fees pursuant to section 552(a)(4)(A)
 of title 5, United States Code.'.
TITLE III--SCIENTIFIC REVIEW GROUPS
SEC. 301. SCIENTIFIC REVIEW GROUPS.
 Chapter IX (21 U.S.C. 391 et seq.) is amended by adding at the end thereof
 the following new section:
`SEC. 903. SCIENTIFIC REVIEW GROUPS.
 Without regard to the provisions of title 5, United States Code, governing
 appointments in the competitive service and without regard to the provisions
 of chapter 51 and subchapter III of chapter 53 of such title relating to
 classification and General Schedule pay rates, the Commissioner of Food
 and Drugs may--
 `(1) establish such technical and scientific review groups as are needed
 to carry out the functions of the Food and Drug Administration (including
 functions prescribed under this Act); and
 `(2) appoint and pay the members of such groups, except that officers and
 employees of the United States shall not receive additional compensation
 for service as members of such groups.'.
TITLE IV--AUTOMATION OF FDA
SEC. 401. AUTOMATION OF FDA.
 Chapter VII (21 U.S.C. 371 et seq.) (as amended by sections 101 and 201
 of this Act) is further amended by adding at the end thereof the following
 new section:
`SEC. 712. AUTOMATION OF FOOD AND DRUG ADMINISTRATION.
 `(a) IN GENERAL- The Secretary, acting through the Commissioner of Food
 and Drugs, shall automate appropriate activities of the Food and Drug
 Administration to ensure timely review of activities regulated under this Act.
 `(b) AUTHORIZATION OF APPROPRIATIONS- There are authorized to be appropriated
 each fiscal year such sums as are necessary to carry out this section.'.
Speaker of the House of Representatives.
Vice President of the United States and
President of the Senate.